Gates Foundation Sells Stake in Britain's G4S
Microsoft Corp co-founder Bill Gates has sold his entire stake in G4S Plc, the British security firm trying to bounce back from a series of scandals that have hurt its reputation and profits.
Cascade Investment, a firm owned by Bill Gates that manages assets exclusively for the Bill & Melinda Gates Foundation Trust, had last June disclosed a stake in G4S, when its holding crossed the 3 per cent threshold for the first time.
A filing on May 28 showed the holding was reduced below 3 per cent, and a spokesman for the Gates Foundation told Reuters on Saturday it no longer held any interest in G4S.
G4S declined comment.
G4S, which runs services such as cash transportation and prison management in more than 125 countries, is in the middle of overhauling its sprawling business, shaking up management, cutting costs, improving customer service and restructuring weak divisions to help revive its fortunes.
Having failed to provide enough security guards for the London 2012 Olympics, G4S suffered another scandal last July when, alongside rival Serco Group Plc, it was banned from new UK government work after being found to have charged for monitoring criminals who were dead, in prison or not tagged at all.
On Thursday, G4S's own security guards ejected protesters from its annual shareholders' meeting, after they criticised the company's work in Israel, where it provides security at prisons and occupied Palestinian territories.
Mr Gates's investments range from stakes in the Canadian National Railway Co to drinks group Diageo Plc.
The Bill and Melinda Gates Foundation works to eradicate the world's most deadly diseases and poverty.
Copyright @ Thomson Reuters 2014
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.